109 related articles for article (PubMed ID: 32337788)
1. Advances on the role of the deleted in breast cancer (DBC1) in cancer and autoimmune diseases.
Fang Q; Bellanti JA; Zheng SG
J Leukoc Biol; 2021 Feb; 109(2):449-454. PubMed ID: 32337788
[TBL] [Abstract][Full Text] [Related]
2. DBC1 is a negative regulator of SIRT1.
Kim JE; Chen J; Lou Z
Nature; 2008 Jan; 451(7178):583-6. PubMed ID: 18235501
[TBL] [Abstract][Full Text] [Related]
3. A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo.
Santos L; Colman L; Contreras P; Chini CC; Carlomagno A; Leyva A; Bresque M; Marmisolle I; Quijano C; Durán R; Irigoín F; Prieto-Echagüe V; Vendelbo MH; Sotelo-Silveira JR; Chini EN; Badano JL; Calliari AJ; Escande C
Sci Rep; 2019 Oct; 9(1):14381. PubMed ID: 31591441
[TBL] [Abstract][Full Text] [Related]
4. hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1.
Zheng H; Yang L; Peng L; Izumi V; Koomen J; Seto E; Chen J
Mol Cell Biol; 2013 Dec; 33(24):4960-70. PubMed ID: 24126058
[TBL] [Abstract][Full Text] [Related]
5. Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage.
Kim W; Kim JE
Cancer Lett; 2013 Jun; 333(2):180-6. PubMed ID: 23352644
[TBL] [Abstract][Full Text] [Related]
6. DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.
Zannini L; Buscemi G; Kim JE; Fontanella E; Delia D
J Mol Cell Biol; 2012 Oct; 4(5):294-303. PubMed ID: 22735644
[TBL] [Abstract][Full Text] [Related]
7. Identification of DBC1 as a transcriptional repressor for BRCA1.
Hiraike H; Wada-Hiraike O; Nakagawa S; Koyama S; Miyamoto Y; Sone K; Tanikawa M; Tsuruga T; Nagasaka K; Matsumoto Y; Oda K; Shoji K; Fukuhara H; Saji S; Nakagawa K; Kato S; Yano T; Taketani Y
Br J Cancer; 2010 Mar; 102(6):1061-7. PubMed ID: 20160719
[TBL] [Abstract][Full Text] [Related]
8. Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis.
Magni M; Ruscica V; Buscemi G; Kim JE; Nachimuthu BT; Fontanella E; Delia D; Zannini L
Nucleic Acids Res; 2014 Dec; 42(21):13150-60. PubMed ID: 25361978
[TBL] [Abstract][Full Text] [Related]
9. Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice.
Escande C; Chini CC; Nin V; Dykhouse KM; Novak CM; Levine J; van Deursen J; Gores GJ; Chen J; Lou Z; Chini EN
J Clin Invest; 2010 Feb; 120(2):545-58. PubMed ID: 20071779
[TBL] [Abstract][Full Text] [Related]
10. A positive role of DBC1 in PEA3-mediated progression of estrogen receptor-negative breast cancer.
Kim HJ; Kim SH; Yu EJ; Seo WY; Kim JH
Oncogene; 2015 Aug; 34(34):4500-8. PubMed ID: 25417701
[TBL] [Abstract][Full Text] [Related]
11. Repression of estrogen receptor beta function by putative tumor suppressor DBC1.
Koyama S; Wada-Hiraike O; Nakagawa S; Tanikawa M; Hiraike H; Miyamoto Y; Sone K; Oda K; Fukuhara H; Nakagawa K; Kato S; Yano T; Taketani Y
Biochem Biophys Res Commun; 2010 Feb; 392(3):357-62. PubMed ID: 20074560
[TBL] [Abstract][Full Text] [Related]
12. Deleted in breast cancer 1 (DBC1) is a dynamically regulated protein.
Kim JE; Sung S
Neoplasma; 2010; 57(4):365-8. PubMed ID: 20429629
[TBL] [Abstract][Full Text] [Related]
13. Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanism.
Hubbard BP; Loh C; Gomes AP; Li J; Lu Q; Doyle TL; Disch JS; Armour SM; Ellis JL; Vlasuk GP; Sinclair DA
Cell Cycle; 2013 Jul; 12(14):2233-40. PubMed ID: 23892437
[TBL] [Abstract][Full Text] [Related]
14. Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.
Lee H; Kim KR; Noh SJ; Park HS; Kwon KS; Park BH; Jung SH; Youn HJ; Lee BK; Chung MJ; Koh DH; Moon WS; Jang KY
Hum Pathol; 2011 Feb; 42(2):204-13. PubMed ID: 21056897
[TBL] [Abstract][Full Text] [Related]
15. MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.
Pangon L; Mladenova D; Watkins L; Van Kralingen C; Currey N; Al-Sohaily S; Lecine P; Borg JP; Kohonen-Corish MR
Int J Cancer; 2015 Jan; 136(1):55-64. PubMed ID: 24824780
[TBL] [Abstract][Full Text] [Related]
16. Deleted in breast cancer-1 (DBC-1) in the interface between metabolism, aging and cancer.
Chini EN; Chini CC; Nin V; Escande C
Biosci Rep; 2013 Aug; 33(4):. PubMed ID: 23841676
[TBL] [Abstract][Full Text] [Related]
17. DBC1/CCAR2 and CCAR1 Are Largely Disordered Proteins that Have Evolved from One Common Ancestor.
Brunquell J; Yuan J; Erwin A; Westerheide SD; Xue B
Biomed Res Int; 2014; 2014():418458. PubMed ID: 25610865
[TBL] [Abstract][Full Text] [Related]
18. Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage.
Park JH; Lee SW; Yang SW; Yoo HM; Park JM; Seong MW; Ka SH; Oh KH; Jeon YJ; Chung CH
Nat Commun; 2014 Nov; 5():5483. PubMed ID: 25406032
[TBL] [Abstract][Full Text] [Related]
19. Balance between SIRT1 and DBC1 expression is lost in breast cancer.
Sung JY; Kim R; Kim JE; Lee J
Cancer Sci; 2010 Jul; 101(7):1738-44. PubMed ID: 20412117
[TBL] [Abstract][Full Text] [Related]
20. Dephosphorylation of DBC1 by Protein Phosphatase 4 Is Important for p53-Mediated Cellular Functions.
Lee J; Adelmant G; Marto JA; Lee DH
Mol Cells; 2015 Aug; 38(8):697-704. PubMed ID: 26194823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]